No CrossRef data available.
Published online by Cambridge University Press: 27 August 2024
Consultations with the Centers for Disease Control and Prevention’s Division of Healthcare Quality Promotion revealed patient harms associated with ophthalmic care. Adherence to core infection prevention and control principles, tailored guidance for ophthalmic settings, and compliance with manufacturing and compounding standards could decrease adverse events and patient exposures to contaminated products.
A portion of this work was presented at SHEA Spring 2023, Abstract 121 (oral), Seattle, WA, USA, April 2023.